Cargando…
3D Exoscopic Surgery (3Des) for Transoral Oropharyngectomy
Over the past three decades, the incidence of oropharyngeal squamous cell carcinoma has increased, primarily related to the spread of human papillomavirus. Treatment has always been preferentially unimodal (surgery or radiotherapy) for early stage disease and multimodal (surgery with adjuvant therap...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006030/ https://www.ncbi.nlm.nih.gov/pubmed/32082996 http://dx.doi.org/10.3389/fonc.2020.00016 |
_version_ | 1783495057830051840 |
---|---|
author | Crosetti, Erika Arrigoni, Giulia Manca, Andrea Caracciolo, Alessandra Bertotto, Ilaria Succo, Giovanni |
author_facet | Crosetti, Erika Arrigoni, Giulia Manca, Andrea Caracciolo, Alessandra Bertotto, Ilaria Succo, Giovanni |
author_sort | Crosetti, Erika |
collection | PubMed |
description | Over the past three decades, the incidence of oropharyngeal squamous cell carcinoma has increased, primarily related to the spread of human papillomavirus. Treatment has always been preferentially unimodal (surgery or radiotherapy) for early stage disease and multimodal (surgery with adjuvant therapy or concomitant chemoradiotherapy) for advanced stages. Recently, the surgical approach has gained renewed interest due to the morbidity of non-surgical treatments and also to technical innovations. We have coined the term 3Des (3D exoscope surgery) to describe the use of the 3D Vitom Exoscope System for transoral surgery of oropharyngeal cancers. During the period from June 2017 to May 2018, 10 patients with oropharyngeal cancer were treated by oropharyngeal surgery with the 3Des approach at FPO IRCCS Institute of Candiolo. The aim of the present prospective study was to evaluate the utility of 3Des for the treatment of early-stage oropharyngeal cancer. 3Des could represent a viable alternative to the operating microscope and robotic surgery thanks to its excellent ability to provide 3D visual information, depth of field, magnification, image contrast, color imaging, and low running costs. It promises great utility in the learning process, with the possibility of recording in high definition. |
format | Online Article Text |
id | pubmed-7006030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70060302020-02-20 3D Exoscopic Surgery (3Des) for Transoral Oropharyngectomy Crosetti, Erika Arrigoni, Giulia Manca, Andrea Caracciolo, Alessandra Bertotto, Ilaria Succo, Giovanni Front Oncol Oncology Over the past three decades, the incidence of oropharyngeal squamous cell carcinoma has increased, primarily related to the spread of human papillomavirus. Treatment has always been preferentially unimodal (surgery or radiotherapy) for early stage disease and multimodal (surgery with adjuvant therapy or concomitant chemoradiotherapy) for advanced stages. Recently, the surgical approach has gained renewed interest due to the morbidity of non-surgical treatments and also to technical innovations. We have coined the term 3Des (3D exoscope surgery) to describe the use of the 3D Vitom Exoscope System for transoral surgery of oropharyngeal cancers. During the period from June 2017 to May 2018, 10 patients with oropharyngeal cancer were treated by oropharyngeal surgery with the 3Des approach at FPO IRCCS Institute of Candiolo. The aim of the present prospective study was to evaluate the utility of 3Des for the treatment of early-stage oropharyngeal cancer. 3Des could represent a viable alternative to the operating microscope and robotic surgery thanks to its excellent ability to provide 3D visual information, depth of field, magnification, image contrast, color imaging, and low running costs. It promises great utility in the learning process, with the possibility of recording in high definition. Frontiers Media S.A. 2020-01-31 /pmc/articles/PMC7006030/ /pubmed/32082996 http://dx.doi.org/10.3389/fonc.2020.00016 Text en Copyright © 2020 Crosetti, Arrigoni, Manca, Caracciolo, Bertotto and Succo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Crosetti, Erika Arrigoni, Giulia Manca, Andrea Caracciolo, Alessandra Bertotto, Ilaria Succo, Giovanni 3D Exoscopic Surgery (3Des) for Transoral Oropharyngectomy |
title | 3D Exoscopic Surgery (3Des) for Transoral Oropharyngectomy |
title_full | 3D Exoscopic Surgery (3Des) for Transoral Oropharyngectomy |
title_fullStr | 3D Exoscopic Surgery (3Des) for Transoral Oropharyngectomy |
title_full_unstemmed | 3D Exoscopic Surgery (3Des) for Transoral Oropharyngectomy |
title_short | 3D Exoscopic Surgery (3Des) for Transoral Oropharyngectomy |
title_sort | 3d exoscopic surgery (3des) for transoral oropharyngectomy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006030/ https://www.ncbi.nlm.nih.gov/pubmed/32082996 http://dx.doi.org/10.3389/fonc.2020.00016 |
work_keys_str_mv | AT crosettierika 3dexoscopicsurgery3desfortransoraloropharyngectomy AT arrigonigiulia 3dexoscopicsurgery3desfortransoraloropharyngectomy AT mancaandrea 3dexoscopicsurgery3desfortransoraloropharyngectomy AT caraccioloalessandra 3dexoscopicsurgery3desfortransoraloropharyngectomy AT bertottoilaria 3dexoscopicsurgery3desfortransoraloropharyngectomy AT succogiovanni 3dexoscopicsurgery3desfortransoraloropharyngectomy |